Grandfield & Dodd’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.47M | Sell |
37,230
-531
| -1% | -$21K | 0.09% | 98 |
|
2025
Q1 | $1.14M | Buy |
37,761
+1,874
| +5% | +$56.5K | 0.07% | 103 |
|
2024
Q4 | $1.25M | Buy |
35,887
+1,074
| +3% | +$37.5K | 0.08% | 101 |
|
2024
Q3 | $1.39M | Buy |
34,813
+760
| +2% | +$30.4K | 0.08% | 97 |
|
2024
Q2 | $1.62M | Buy |
34,053
+279
| +0.8% | +$13.3K | 0.1% | 90 |
|
2024
Q1 | $1.46M | Buy |
33,774
+670
| +2% | +$29K | 0.09% | 94 |
|
2023
Q4 | $1.67M | Buy |
33,104
+242
| +0.7% | +$12.2K | 0.12% | 87 |
|
2023
Q3 | $1.49M | Buy |
32,862
+183
| +0.6% | +$8.3K | 0.11% | 86 |
|
2023
Q2 | $1.34M | Buy |
32,679
+395
| +1% | +$16.2K | 0.09% | 94 |
|
2023
Q1 | $1.15M | Buy |
32,284
+810
| +3% | +$28.9K | 0.08% | 98 |
|
2022
Q4 | $1.19M | Buy |
31,474
+2,403
| +8% | +$90.8K | 0.09% | 95 |
|
2022
Q3 | $1.29M | Buy |
29,071
+795
| +3% | +$35.3K | 0.11% | 89 |
|
2022
Q2 | $1.05M | Buy |
28,276
+275
| +1% | +$10.2K | 0.08% | 97 |
|
2022
Q1 | $1.04M | Buy |
28,001
+1,230
| +5% | +$45.7K | 0.07% | 100 |
|
2021
Q4 | $810K | Buy |
26,771
+5,080
| +23% | +$154K | 0.05% | 113 |
|
2021
Q3 | $730K | Buy |
21,691
+638
| +3% | +$21.5K | 0.05% | 116 |
|
2021
Q2 | $840K | Buy |
21,053
+700
| +3% | +$27.9K | 0.06% | 109 |
|
2021
Q1 | $920K | Buy |
20,353
+711
| +4% | +$32.1K | 0.07% | 101 |
|
2020
Q4 | $1.11M | Buy |
19,642
+605
| +3% | +$34.2K | 0.09% | 92 |
|
2020
Q3 | $900K | Buy |
19,037
+336
| +2% | +$15.9K | 0.08% | 97 |
|
2020
Q2 | $1.1M | Buy |
18,701
+1,365
| +8% | +$80.3K | 0.11% | 89 |
|
2020
Q1 | $820K | Buy |
17,336
+660
| +4% | +$31.2K | 0.1% | 94 |
|
2019
Q4 | $1.01M | Buy |
16,676
+855
| +5% | +$51.6K | 0.09% | 95 |
|
2019
Q3 | $948K | Buy |
15,821
+1,170
| +8% | +$70.1K | 0.09% | 92 |
|
2019
Q2 | $942K | Buy |
14,651
+808
| +6% | +$52K | 0.09% | 95 |
|
2019
Q1 | $1.12M | Buy |
13,843
+99
| +0.7% | +$8.04K | 0.12% | 87 |
|
2018
Q4 | $743K | Buy |
13,744
+165
| +1% | +$8.92K | 0.09% | 101 |
|
2018
Q3 | $700K | Buy |
13,579
+110
| +0.8% | +$5.67K | 0.07% | 110 |
|
2018
Q2 | $561K | Buy |
13,469
+80
| +0.6% | +$3.33K | 0.06% | 121 |
|
2018
Q1 | $590K | Sell |
13,389
-280
| -2% | -$12.3K | 0.07% | 115 |
|
2017
Q4 | $688K | Buy |
13,669
+290
| +2% | +$14.6K | 0.07% | 111 |
|
2017
Q3 | $678K | Buy |
13,379
+570
| +4% | +$28.9K | 0.08% | 111 |
|
2017
Q2 | $652K | Buy |
12,809
+690
| +6% | +$35.1K | 0.08% | 113 |
|
2017
Q1 | $487K | Buy |
12,119
+135
| +1% | +$5.43K | 0.06% | 129 |
|
2016
Q4 | $573K | Buy |
11,984
+1,580
| +15% | +$75.5K | 0.07% | 115 |
|
2016
Q3 | $381K | Sell |
10,404
-780
| -7% | -$28.6K | 0.05% | 135 |
|
2016
Q2 | $260K | Buy |
11,184
+2,574
| +30% | +$59.8K | 0.04% | 155 |
|
2016
Q1 | $349K | Buy |
8,610
+3,235
| +60% | +$131K | 0.05% | 132 |
|
2015
Q4 | $333K | Buy |
+5,375
| New | +$333K | 0.05% | 138 |
|
2015
Q3 | – | Sell |
-3,700
| Closed | -$213K | – | 173 |
|
2015
Q2 | $213K | Buy |
+3,700
| New | +$213K | 0.03% | 166 |
|